SENSEX NIFTY

Mylan

Apr 13, 2017 at 20:59 | Source: PTI
During the inspection, the FDA investigator observed specific violations such as the quality system not fully ensuring data integrity, the regulator said.
Mar 03, 2017 at 11:26 | Source: CNBC-TV18
Biocon Chief Kiran Mazumdar Shaw says India is not an outsourced services country anymore, it is an innovation and knowledge partner.
Mar 02, 2017 at 19:00 | Source: PTI
"Once the designated authority has given approval, you cannot say prima facie you have case over that. Till that (approval) is disturbed by an order of the court, it will remain," a bench of justices Badar Durrez Ahmed and Sanjeev Sachdeva said.
Feb 22, 2017 at 20:38 | Source: PTI
The Delhi High Court today told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the rest of its life after having enjoyed the fruits of its patent.
Feb 17, 2017 at 15:29 | Source: Moneycontrol.com
Biocon shares gained 2.6 percent to hit a record high of Rs 1,123 after the US health regulator USFDA has accepted pharma major Mylan's biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim.
Feb 17, 2017 at 14:50 | Source: PTI
US health regulator USFDA hasaccepted pharma major Mylan's biologics licence application(BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim,Biocon and Mylan have said.
Feb 17, 2017 at 09:51 | Source: CNBC-TV18
Biocon Thursday announced the US Food and Drug Administration has accepted Mylans Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and Managing Director Kiran Mazumdar Shaw said, "This is a very important acceptance."
Feb 03, 2017 at 18:24 | Source: PTI
Pharma major Lupin today said it has received final approval from the US health regulator to market its generic version of Mylan's triamcinolone acetonide cream used for treatment of skin disease.
Feb 03, 2017 at 16:00 | Source: Moneycontrol.com
Lupin has received final approval for its Triamcinolone Acetonide cream USP, 0.025 percent, 0.1 percent and 0.5 percent from the United States Food and Drug Administration to market a generic equivalent of Mylan Pharmaceuticals Incs Triamcinolone Acetonide cream.
Jan 31, 2017 at 18:45 | Source: Moneycontrol.com
Natco and Mylan believe that they are the first companies to have filed a substantially complete abbreviated new drug application containing a Para-IV certification for a 3 times per week Glatiramer Acetate Injection 40 mg/mL, and expect 180 days of marketing exclusivity in the US.
Messages on Mylan »

lizzy

Platinum Member

41 Followers

Claris Life  

and geographic expansion. There have been a couple of other big deals in this space. In 2013, Strides Arcolab Ltd sold its injectables unit, Agila Specialties, to US-based Mylan Inc. for $1.6 billion. In July last year, Shanghai Fosun Pharmaceutical (Group) Co. Ltd said it will acquire India s Gland Pharma Ltd

10.28 AM Apr 18th

unseenvalue

Gold Member

441 Followers

Neuland Lab  

Why did GSK share price not react positively to this? Surely if Mylan has been delayed indefinitely - GSK would be the prime beneficiary! Sherlock Holmes - please investigate this -:) BTW: Hikma`s decision will be out in May2017

2.41 PM Apr 2nd

akrmr1

New Member

20 Followers

Neuland Lab  

suddenly so many comments and prop talk...good company no doubt but everything takes time...at this point of time scrip appears highly over priced..there was no reaction to Mylan`s rejection of Advair....accumulate only on declines....31st march game is over....

10.08 PM Apr 1st

savera_patn
a

Platinum Member

43 Followers

Biocon  

Mylan insulin glargine extension trial completion date march 2017 ..... Next filing with usfda with interchangeable tag

10.15 AM Apr 1st

cpmc

Silver Member

47 Followers

Natco Pharma  

How is Natco related with HIV drugs? This news would be fine for Cipla, Hetero, Mylan and the like, not for Natco.

3.39 PM Mar 29th

Cupid  

mylan lookng to acquire cupid

1.10 PM Mar 27th

Cupid  

mylan lookng to acquire cupid

1.10 PM Mar 27th

PARAS GOLD

New Member

12 Followers

Biocon  

mylan approval has cleare d all doubts on future f d a approvals for biosimilar says kiran majumdar ceo on et now now see huge q4 results and eps of 55 to 65

1.03 PM Mar 21st

conray

New Member

4 Followers

Sun Pharma  

sun pharma, mylan face price fixing charges in us. suit also filed against sandoz and mylan for colluding to hike price of another respiratory drug.....it is falling because of this news

12.12 PM Mar 21st

savera_patn
a

Platinum Member

43 Followers

Biocon  

http://t.in.com/e6Rv Mylan and partner Biocon cleared another hurdle with their version of Roche’s breast cancer med Herceptin, one of the biggest biosim targets in the market.

8.48 PM Mar 14th

News across the web »
Follow us on
Available On